FDA Approves AstraZeneca’s IMFINZI® (durvalumab) Plus Chemotherapy to Treat Severe Types of Endometrial Cancer

FDA Approves AstraZeneca’s IMFINZI® (durvalumab) Plus Chemotherapy to Treat Severe Types of Endometrial Cancer

AstraZeneca’s IMFINZI® (durvalumab) plus chemotherapy has been approved by the US Food and Drug Administration (FDA) for the treatment of adult patients struggling with mismatch repair deficient (dMMR) advanced or recurrent endometrial cancer. According to the company’s announcement on Monday, June 18, its latest therapy, IMFINZI® (durvalumab), combined with paclitaxel and carboplatin, followed by the latest IMFINZI monotherapy, have been approved based on prespecified exploratory subgroup results analysis in the DUO-E Phase III.

Please login to comment on this Post

Most Visited Posts

1

Business August 06, 2024

Sofort Wohnungsauflösung von 80 Euro

Wir machen alles sofort am gleichen oder an...

2

Business January 06, 2025

Buy Blue Dolphin MDMA pills online

Blue Dolphin – MDMA pills for vibrant...

3

Business September 30, 2024

From Ingredients to Impact: Exploring the Dynamics of the Global Prebiotics Market

Meticulous Research®, a prominent global...

4

Business April 26, 2025

How Regular Carpet Cleaning Makes Your Home More Inviting

Introduction An easy and alluring domestic...

5

Travel July 06, 2023

Desert Safari ATV Services in Abu Dhabi

We specialize in providing the ultimate desert adventure, with a wide range of tour options to choose from. Whether you’re looking for an adrenaline-pumping dune bashing experience or a Desert Safari ATV Services in Abu Dhabi, we’ve got you covered.